Laura Camus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laura Camus has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- François Vandenesch
University Hospital Microbiology Laboratory, Hospices Civils de Lyon, 69004 Lyon, France
6 shared publications - Karen Moreau
CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon
6 shared publications - Paul Briaud
CIRI
5 shared publications - Simon Heilbronner
Faculty of Biology, Microbiology, Ludwig-Maximilians-University of Munich, 82152 München, Germany
4 shared publications - Anne Doléans-Jordheim
Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, 69007 Lyon, France
3 shared publications - Sylvère Bastien
CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon
3 shared publications
Latest Publications
- 26 October 2026
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 76 (10) , 007292
Characterization of Corynebacterium species isolated from nasal swabs of healthy volunteers: description of Corynebacterium nasorum sp. nov., Corynebacterium tardum sp. nov., Corynebacterium tuingiense sp. nov., Corynebacterium limaceinasi sp. nov. and Corynebacterium kefirresidentii sp. nov.
Members of the genus Corynebacterium are common constituents of the human nasal microbiota but their cultivable diversity remains incompletely represented in taxonomic and diagnostic databases. Ten coryneform strains isolated from nasal swabs of seven healthy adults were characterized using matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS), whole-genome sequencing, phylogenomic inference, overall genome relatedness indices, phenotypic testing and chemotaxonomic analyses. MALDI-TOF MS initially assigned most strains to Corynebacterium tuberculostearicum or Corynebacterium accolens , whereas genome-based analyses resolved the strains into five distinct species-level lineages. The lineages represented by strains LaCa116 T , LaCa142 T and LaCa191 T were clearly differentiated from their closest related type strains by average nucleotide identity (ANI) and digital DNA–DNA hybridization (dDDH) values below accepted species-level thresholds. Strains LaCa7 T and LaCa117 T represented closely related but distinguishable genomic lineages, with an ANI value of 95.9% and a dDDH value of 66.4%. Strain LaCa117 T was closely related to strain SB, to which the effectively but not validly published name ‘ Corynebacterium kefirresidentii ’ had previously been applied. Phenotypic and chemotaxonomic characteristics supported the genomic groupings and placement of the strains within the genus Corynebacterium . These findings reveal previously unrecognized diversity among cultivable nasal corynebacteria and demonstrate that routine MALDI-TOF MS identification may be unreliable when suitable reference spectra are absent. Based on the integrated taxonomic evidence, the names Corynebacterium nasorum sp. nov. (type strain LaCa7 T =DSM 119349 T =LMG 33882 T ), Corynebacterium kefirresidentii sp. nov. (type strain LaCa117 T =DSM 119343 T =LMG 33886 T ), Corynebacterium tuingiense sp. nov. (type strain LaCa142 T =DSM 119342 T =LMG 33884 T ), Corynebacterium limaceinasi sp. nov. (type strain LaCa191 T =DSM 119341 T =LMG 33883 T ) and Corynebacterium tardum sp. nov. (type strain LaCa116 T =DSM 119344 T =LMG 33885 T ) are proposed.
- 26 October 2026
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 76 (10) , 007292
Characterization of Corynebacterium species isolated from nasal swabs of healthy volunteers: description of Corynebacterium nasorum sp. nov., Corynebacterium tardum sp. nov., Corynebacterium tuingiense sp. nov., Corynebacterium limaceinasi sp. nov. and Corynebacterium kefirresidentii sp. nov.
Members of the genus Corynebacterium are common constituents of the human nasal microbiota but their cultivable diversity remains incompletely represented in taxonomic and diagnostic databases. Ten coryneform strains isolated from nasal swabs of seven healthy adults were characterized using matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS), whole-genome sequencing, phylogenomic inference, overall genome relatedness indices, phenotypic testing and chemotaxonomic analyses. MALDI-TOF MS initially assigned most strains to Corynebacterium tuberculostearicum or Corynebacterium accolens , whereas genome-based analyses resolved the strains into five distinct species-level lineages. The lineages represented by strains LaCa116 T , LaCa142 T and LaCa191 T were clearly differentiated from their closest related type strains by average nucleotide identity (ANI) and digital DNA–DNA hybridization (dDDH) values below accepted species-level thresholds. Strains LaCa7 T and LaCa117 T represented closely related but distinguishable genomic lineages, with an ANI value of 95.9% and a dDDH value of 66.4%. Strain LaCa117 T was closely related to strain SB, to which the effectively but not validly published name ‘ Corynebacterium kefirresidentii ’ had previously been applied. Phenotypic and chemotaxonomic characteristics supported the genomic groupings and placement of the strains within the genus Corynebacterium . These findings reveal previously unrecognized diversity among cultivable nasal corynebacteria and demonstrate that routine MALDI-TOF MS identification may be unreliable when suitable reference spectra are absent. Based on the integrated taxonomic evidence, the names Corynebacterium nasorum sp. nov. (type strain LaCa7 T =DSM 119349 T =LMG 33882 T ), Corynebacterium kefirresidentii sp. nov. (type strain LaCa117 T =DSM 119343 T =LMG 33886 T ), Corynebacterium tuingiense sp. nov. (type strain LaCa142 T =DSM 119342 T =LMG 33884 T ), Corynebacterium limaceinasi sp. nov. (type strain LaCa191 T =DSM 119341 T =LMG 33883 T ) and Corynebacterium tardum sp. nov. (type strain LaCa116 T =DSM 119344 T =LMG 33885 T ) are proposed.
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Décryptage des interactions bactériennes entre Pseudomonas aeruginosa et Staphylococcus aureus dans un contexte d'infection pulmonaire
Les patients atteints de mucoviscidose souffrent d’infections pulmonaires polymicrobiennes dont les principaux agents d’intérêt clinique sont Staphylococcus aureus et Pseudomonas aeruginosa. Ces deux bactéries co-infectent jusqu’à 40% des patients et sont capables, dans ces conditions, d’interagir de deux façons différentes. Les souches d’infection précoce de P. aeruginosa sont dans un état de compétition avec S. aureus, alors que les souches d’infection chronique sont capables de coexister. Ce dernier état reste peu décrit mais pourrait favoriser la persistance des deux pathogènes dans les poumons des patients. Nous cherchons donc à comprendre les mécanismes de cet état de coexistence par l’étude de souches cliniques. Nous avons tout d’abord étudié l’impact de la coexistence sur la physiologie bactérienne de P. aeruginosa par une approche transcriptomique, et avons mis en évidence une coopération trophique entre les deux espèces. La production d’acétoine par S. aureus et le catabolisme de cette molécule par P. aeruginosa favorisent ainsi la survie des deux pathogènes lors de leur interaction. Parallèlement à cela, nous avons étudié les facteurs génétiques de P. aeruginosa impliqués dans l’établissement et le maintien de la coexistence avec S. aureus. Différentes approches ont été utilisées : (i) le séquençage de souches isolées de patients présentant différents états d’interaction ; (ii) l’établissement d’un protocole d’évolution expérimentale in vitro et (iii) le criblage d’une banque de mutants par Transposon-sequencing. Ces approches ont permis l’identification de deux facteurs impliqués dans l’établissement de l’état de coexistence : le gène codant pour le régulateur du quorum-sensing lasR, et l’opéron yecS-fliY, impliqué dans le transport de la cystéine. Le maintien P. aeruginosa dans cet état de coexistence avec S. aureus semble quant à lui faire intervenir la synthèse de différents acides aminés et le métabolisme du glucose de P. aeruginosa. Ces travaux ont donc démontré l’importance du métabolisme carboné de P. aeruginosa dans l’interaction de coexistence avec S. aureus, et ont permis de mieux comprendre les causes et impacts de cet état encore peu décrit. Ces résultats ouvrent également de nombreuses perspectives pour l’étude des interactions entre P. aeruginosa et S. aureus
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Décryptage des interactions bactériennes entre Pseudomonas aeruginosa et Staphylococcus aureus dans un contexte d'infection pulmonaire
Les patients atteints de mucoviscidose souffrent d’infections pulmonaires polymicrobiennes dont les principaux agents d’intérêt clinique sont Staphylococcus aureus et Pseudomonas aeruginosa. Ces deux bactéries co-infectent jusqu’à 40% des patients et sont capables, dans ces conditions, d’interagir de deux façons différentes. Les souches d’infection précoce de P. aeruginosa sont dans un état de compétition avec S. aureus, alors que les souches d’infection chronique sont capables de coexister. Ce dernier état reste peu décrit mais pourrait favoriser la persistance des deux pathogènes dans les poumons des patients. Nous cherchons donc à comprendre les mécanismes de cet état de coexistence par l’étude de souches cliniques. Nous avons tout d’abord étudié l’impact de la coexistence sur la physiologie bactérienne de P. aeruginosa par une approche transcriptomique, et avons mis en évidence une coopération trophique entre les deux espèces. La production d’acétoine par S. aureus et le catabolisme de cette molécule par P. aeruginosa favorisent ainsi la survie des deux pathogènes lors de leur interaction. Parallèlement à cela, nous avons étudié les facteurs génétiques de P. aeruginosa impliqués dans l’établissement et le maintien de la coexistence avec S. aureus. Différentes approches ont été utilisées : (i) le séquençage de souches isolées de patients présentant différents états d’interaction ; (ii) l’établissement d’un protocole d’évolution expérimentale in vitro et (iii) le criblage d’une banque de mutants par Transposon-sequencing. Ces approches ont permis l’identification de deux facteurs impliqués dans l’établissement de l’état de coexistence : le gène codant pour le régulateur du quorum-sensing lasR, et l’opéron yecS-fliY, impliqué dans le transport de la cystéine. Le maintien P. aeruginosa dans cet état de coexistence avec S. aureus semble quant à lui faire intervenir la synthèse de différents acides aminés et le métabolisme du glucose de P. aeruginosa. Ces travaux ont donc démontré l’importance du métabolisme carboné de P. aeruginosa dans l’interaction de coexistence avec S. aureus, et ont permis de mieux comprendre les causes et impacts de cet état encore peu décrit. Ces résultats ouvrent également de nombreuses perspectives pour l’étude des interactions entre P. aeruginosa et S. aureus
- Open Access
Tyrosine availability shapes Staphylococcus aureus nasal colonization and interactions with commensal communities
Only certain individuals are nasally colonized by Staphylococcus aureus , making them more susceptible to developing endogenous infections. The role of the resident microbiota in modulating S. aureus nasal colonization remains largely unclear. Using a newly assembled nasal strain collection, we demonstrate that nasal commensals can either promote or inhibit S. aureus proliferation through strain- and community-specific effects in vitro and within gnotobiotic animals. We identified nutrient-dependent interactions as a key driver of these dynamics and found that S. aureus strains auxotrophic to tyrosine rely on amino acid-providing nasal communities to thrive in the nutrient-limited environment of the nose. Large-scale screenings revealed tyrosine dependency to affect 8% of nasal S. aureus strains and to impair S. aureus colonization. Our findings uncover a crucial factor in S. aureus physiology and its interactions as a commensal nasal species, paving the way for new decolonization strategies. Graphical
Open AccessTyrosine availability shapes Staphylococcus aureus nasal colonization and interactions with commensal communities
Only certain individuals are nasally colonized by Staphylococcus aureus , making them more susceptible to developing endogenous infections. The role of the resident microbiota in modulating S. aureus nasal colonization remains largely unclear. Using a newly assembled nasal strain collection, we demonstrate that nasal commensals can either promote or inhibit S. aureus proliferation through strain- and community-specific effects in vitro and within gnotobiotic animals. We identified nutrient-dependent interactions as a key driver of these dynamics and found that S. aureus strains auxotrophic to tyrosine rely on amino acid-providing nasal communities to thrive in the nutrient-limited environment of the nose. Large-scale screenings revealed tyrosine dependency to affect 8% of nasal S. aureus strains and to impair S. aureus colonization. Our findings uncover a crucial factor in S. aureus physiology and its interactions as a commensal nasal species, paving the way for new decolonization strategies. Graphical
- Open Access
- 2 January 2025
- Published by Oxford University Press (OUP) in The ISME Journal
- Vol. 19 (1)
Competitive fitness of Staphylococcus aureus against nasal commensals depends on biotin biosynthesis and acquisition
The human nasal microbiome can serve as a reservoir for pathogens. In particular, the opportunistic pathogen Staphylococcus aureus can be a member of the nasal microbiome increasing the risk of subsequent infections. The nasal carriage of S. aureus is known to be positively and negatively impacted by nonpathogenic species, suggesting interactions between the pathogen and commensals, but the underlying molecular mechanism remains largely unclear. Herein we demonstrate that S. aureus competes with nasal commensals for the coenzyme biotin. Biotin is crucial for all living organisms and we show that depletion of biotin impairs S. aureus growth and membrane integrity. We found the nasal cavity to be a biotin-limited environment, suggesting competition for the coenzyme within the microbiome. For some nasal commensals and S. aureus, we observed biotin prototrophy and all strains released biotin into the environment. In contrast, other commensals and especially coagulase-negative staphylococci (CoNS) were found to be biotin auxotrophs and strongly reliant on prototrophic strains under biotin-limited conditions. We show that high-affinity biotin uptake systems are used by prototrophic and auxotrophic strains alike and represent crucial factors to optimize competitive fitness of species in co-culture. Together, our data show that biotin-mediated interactions occur between the species of the human nasal microbiome and provide evidence for interspecies competition and co-dependency.
- 2 January 2025
- Published by Oxford University Press (OUP) in The ISME Journal
- Vol. 19 (1)
Open AccessCompetitive fitness of Staphylococcus aureus against nasal commensals depends on biotin biosynthesis and acquisition
The human nasal microbiome can serve as a reservoir for pathogens. In particular, the opportunistic pathogen Staphylococcus aureus can be a member of the nasal microbiome increasing the risk of subsequent infections. The nasal carriage of S. aureus is known to be positively and negatively impacted by nonpathogenic species, suggesting interactions between the pathogen and commensals, but the underlying molecular mechanism remains largely unclear. Herein we demonstrate that S. aureus competes with nasal commensals for the coenzyme biotin. Biotin is crucial for all living organisms and we show that depletion of biotin impairs S. aureus growth and membrane integrity. We found the nasal cavity to be a biotin-limited environment, suggesting competition for the coenzyme within the microbiome. For some nasal commensals and S. aureus, we observed biotin prototrophy and all strains released biotin into the environment. In contrast, other commensals and especially coagulase-negative staphylococci (CoNS) were found to be biotin auxotrophs and strongly reliant on prototrophic strains under biotin-limited conditions. We show that high-affinity biotin uptake systems are used by prototrophic and auxotrophic strains alike and represent crucial factors to optimize competitive fitness of species in co-culture. Together, our data show that biotin-mediated interactions occur between the species of the human nasal microbiome and provide evidence for interspecies competition and co-dependency.
- Open Access
Genome-scale metabolic models consistently predict in vitro characteristics of Corynebacterium striatum
Genome-scale metabolic models (GEMs) are organism specific knowledge bases which can be used to unravel pathogenicity or improve production of specific metabolites in biotechnology applications. The present work combines in silico and in vitro approaches to create and curate strain-specific genome-scale metabolic models of Corynebacterium striatum . Approaches towards modeling rarely studied organisms are scarce. We introduce a cost-effective and easy experimental protocol which can be adapted to other organisms as well. Furthermore, the comparability of growth kinetics and in silico growth rates is discussed. This work introduces five newly created strain-specific genome-scale metabolic models (GEMs) of high quality, satisfying all contemporary standards and requirements. All these models have been benchmarked using the community standard test suite Metabolic Model Testing (MEMOTE) and experimentally validated by laboratory experiments conducted specifically for this purpose. For the curation of those models, the software infrastructure refineGEMs was developed to work on these models in parallel and to comply with the quality standards for GEMs. The model predictions were confirmed by experimental data and a new comparison metric based on the doubling time was developed to quantify bacterial growth. Future modeling projects can rely on the proposed software, which is independent of specific environmental conditions. The validation approach based on the growth rate calculation is now accessible and closely aligned with biological questions. The curated models are freely available via BioModels and a GitHub repository and can be used. The open-source software refineGEMs is available from https://github.com/draeger-lab/refinegems .
Open AccessGenome-scale metabolic models consistently predict in vitro characteristics of Corynebacterium striatum
Genome-scale metabolic models (GEMs) are organism specific knowledge bases which can be used to unravel pathogenicity or improve production of specific metabolites in biotechnology applications. The present work combines in silico and in vitro approaches to create and curate strain-specific genome-scale metabolic models of Corynebacterium striatum . Approaches towards modeling rarely studied organisms are scarce. We introduce a cost-effective and easy experimental protocol which can be adapted to other organisms as well. Furthermore, the comparability of growth kinetics and in silico growth rates is discussed. This work introduces five newly created strain-specific genome-scale metabolic models (GEMs) of high quality, satisfying all contemporary standards and requirements. All these models have been benchmarked using the community standard test suite Metabolic Model Testing (MEMOTE) and experimentally validated by laboratory experiments conducted specifically for this purpose. For the curation of those models, the software infrastructure refineGEMs was developed to work on these models in parallel and to comply with the quality standards for GEMs. The model predictions were confirmed by experimental data and a new comparison metric based on the doubling time was developed to quantify bacterial growth. Future modeling projects can rely on the proposed software, which is independent of specific environmental conditions. The validation approach based on the growth rate calculation is now accessible and closely aligned with biological questions. The curated models are freely available via BioModels and a GitHub repository and can be used. The open-source software refineGEMs is available from https://github.com/draeger-lab/refinegems .
- 19 October 2022
- Published by Springer Nature
- Vol. 1386, 397-424
Mixed Populations and Co-Infection: Pseudomonas aeruginosa and Staphylococcus aureus
The human pathogens Pseudomonas aeruginosa and Staphylococcus aureus are frequently co-isolated from chronic wounds or cystic fibrosis patient airways. Clinical studies analysing the impact of co-infection on patient clinical outcomes lead to contradictory results. However, laboratory approaches suggest that the two pathogens co-colonize the same infection niches and form a mixed-species biofilm, therefore favouring their resistance to antibiotics and immune response. In parallel, many recent studies have focused on the different interactions between the two bacterial species. It has long been recognized that P. aeruginosa usually outcompetes S. aureus, and the molecular mechanisms involved in this state of bacterial competition are now well understood. However, several recent studies show that interactions between P. aeruginosa and S. aureus can be diverse and evolve over time. Thus, many CF isolates of P. aeruginosa and S. aureus can coexist and develop cooperative behaviours. In this chapter, we will provide an overview of the current knowledge on the mixed populations of P. aeruginosa and S. aureus, from their mechanisms of establishment to their impacts on bacterial physiology and clinical outcomes. Keywords Pseudomonas aeruginosa Staphylococcus aureus Co-infection Clinical outcomes Host response Mixed biofilm Bacterial interaction Competition Coexistence
- 19 October 2022
- Published by Springer Nature
- Vol. 1386, 397-424
Mixed Populations and Co-Infection: Pseudomonas aeruginosa and Staphylococcus aureus
The human pathogens Pseudomonas aeruginosa and Staphylococcus aureus are frequently co-isolated from chronic wounds or cystic fibrosis patient airways. Clinical studies analysing the impact of co-infection on patient clinical outcomes lead to contradictory results. However, laboratory approaches suggest that the two pathogens co-colonize the same infection niches and form a mixed-species biofilm, therefore favouring their resistance to antibiotics and immune response. In parallel, many recent studies have focused on the different interactions between the two bacterial species. It has long been recognized that P. aeruginosa usually outcompetes S. aureus, and the molecular mechanisms involved in this state of bacterial competition are now well understood. However, several recent studies show that interactions between P. aeruginosa and S. aureus can be diverse and evolve over time. Thus, many CF isolates of P. aeruginosa and S. aureus can coexist and develop cooperative behaviours. In this chapter, we will provide an overview of the current knowledge on the mixed populations of P. aeruginosa and S. aureus, from their mechanisms of establishment to their impacts on bacterial physiology and clinical outcomes. Keywords Pseudomonas aeruginosa Staphylococcus aureus Co-infection Clinical outcomes Host response Mixed biofilm Bacterial interaction Competition Coexistence
- Open Access
- 1 March 2021
- Published by Microbiology Society in Microbial Genomics
- Vol. 7 (3) , 000513
From genotype to phenotype: adaptations of Pseudomonas aeruginosa to the cystic fibrosis environment
Pseudomonas aeruginosa is one of the main microbial species colonizing the lungs of cystic fibrosis patients and is responsible for the decline in respiratory function. Despite the hostile pulmonary environment, P. aeruginosa is able to establish chronic infections thanks to its strong adaptive capacity. Various longitudinal studies have attempted to compare the strains of early infection with the adapted strains of chronic infection. Thanks to new ‘-omics’ techniques, convergent genetic mutations, as well as transcriptomic and proteomic dysregulations have been identified. As a consequence of this evolution, the adapted strains of P. aeruginosa have particular phenotypes that promote persistent infection.
- 1 March 2021
- Published by Microbiology Society in Microbial Genomics
- Vol. 7 (3) , 000513
Open AccessFrom genotype to phenotype: adaptations of Pseudomonas aeruginosa to the cystic fibrosis environment
Pseudomonas aeruginosa is one of the main microbial species colonizing the lungs of cystic fibrosis patients and is responsible for the decline in respiratory function. Despite the hostile pulmonary environment, P. aeruginosa is able to establish chronic infections thanks to its strong adaptive capacity. Various longitudinal studies have attempted to compare the strains of early infection with the adapted strains of chronic infection. Thanks to new ‘-omics’ techniques, convergent genetic mutations, as well as transcriptomic and proteomic dysregulations have been identified. As a consequence of this evolution, the adapted strains of P. aeruginosa have particular phenotypes that promote persistent infection.
- 19 August 2020
- Published by Oxford University Press (OUP) in The ISME Journal
- Vol. 14 (12) , 3093-3105
Trophic cooperation promotes bacterial survival of Staphylococcus aureus and Pseudomonas aeruginosa
In the context of infection, Pseudomonas aeruginosa and Staphylococcus aureus are frequently co-isolated, particularly in cystic fibrosis (CF) patients. Within lungs, the two pathogens exhibit a range of competitive and coexisting interactions. In the present study, we explored the impact of S. aureus on the physiology of P. aeruginosa in the context of coexistence. Transcriptomic analyses showed that S. aureus significantly and specifically affects the expression of numerous genes involved in P. aeruginosa carbon and amino acid metabolism. In particular, 65% of the strains presented considerable overexpression of the genes involved in the acetoin catabolic (aco) pathway. We demonstrated that acetoin is (i) produced by clinical S. aureus strains, (ii) detected in sputa from CF patients and (iii) involved in P. aeruginosa’s aco system induction. Furthermore, acetoin is catabolized by P. aeruginosa, a metabolic process that improves the survival of both pathogens by providing a new carbon source for P. aeruginosa and avoiding the toxic accumulation of acetoin on S. aureus. Due to its beneficial effects on both bacteria, acetoin catabolism could testify to the establishment of trophic cooperation between S. aureus and P. aeruginosa in the CF lung environment, thus promoting their persistence.
- 19 August 2020
- Published by Oxford University Press (OUP) in The ISME Journal
- Vol. 14 (12) , 3093-3105
Trophic cooperation promotes bacterial survival of Staphylococcus aureus and Pseudomonas aeruginosa
In the context of infection, Pseudomonas aeruginosa and Staphylococcus aureus are frequently co-isolated, particularly in cystic fibrosis (CF) patients. Within lungs, the two pathogens exhibit a range of competitive and coexisting interactions. In the present study, we explored the impact of S. aureus on the physiology of P. aeruginosa in the context of coexistence. Transcriptomic analyses showed that S. aureus significantly and specifically affects the expression of numerous genes involved in P. aeruginosa carbon and amino acid metabolism. In particular, 65% of the strains presented considerable overexpression of the genes involved in the acetoin catabolic (aco) pathway. We demonstrated that acetoin is (i) produced by clinical S. aureus strains, (ii) detected in sputa from CF patients and (iii) involved in P. aeruginosa’s aco system induction. Furthermore, acetoin is catabolized by P. aeruginosa, a metabolic process that improves the survival of both pathogens by providing a new carbon source for P. aeruginosa and avoiding the toxic accumulation of acetoin on S. aureus. Due to its beneficial effects on both bacteria, acetoin catabolism could testify to the establishment of trophic cooperation between S. aureus and P. aeruginosa in the CF lung environment, thus promoting their persistence.
- Open Access
Trophic cooperation promotes bacterial survival of Staphylococcus aureus and Pseudomonas aeruginosa
In the context of infection, Pseudomonas aeruginosa and Staphylococcus aureus are frequently co-isolated, particularly in cystic fibrosis (CF) patients. Within lungs, the two pathogens exhibit a range of competitive and coexisting interactions. In the present study, we explored the impact of S. aureus on the physiology of P. aeruginosa in the context of coexistence. Transcriptomic analyses showed that S. aureus significantly and specifically affects the expression of numerous genes involved in P. aeruginosa carbon and amino acid metabolism. In particular, 65% of the strains presented considerable overexpression of the genes involved in the acetoin catabolic ( aco ) pathway. We demonstrated that acetoin is (i) produced by clinical S. aureus strains, (ii) detected in sputa from CF patients, and (iii) involved in P. aeruginosa’s aco system induction. Furthermore, acetoin is catabolized by P. aeruginosa , a metabolic process that improves the survival of both pathogens by providing a new carbon source for P. aeruginosa and avoiding the toxic accumulation of acetoin on S. aureus . Due to its beneficial effects on both bacteria, acetoin catabolism could testify to the establishment of trophic cooperation between S. aureus and P. aeruginosa in the CF lung environment, thus promoting their persistence.
Open AccessTrophic cooperation promotes bacterial survival of Staphylococcus aureus and Pseudomonas aeruginosa
In the context of infection, Pseudomonas aeruginosa and Staphylococcus aureus are frequently co-isolated, particularly in cystic fibrosis (CF) patients. Within lungs, the two pathogens exhibit a range of competitive and coexisting interactions. In the present study, we explored the impact of S. aureus on the physiology of P. aeruginosa in the context of coexistence. Transcriptomic analyses showed that S. aureus significantly and specifically affects the expression of numerous genes involved in P. aeruginosa carbon and amino acid metabolism. In particular, 65% of the strains presented considerable overexpression of the genes involved in the acetoin catabolic ( aco ) pathway. We demonstrated that acetoin is (i) produced by clinical S. aureus strains, (ii) detected in sputa from CF patients, and (iii) involved in P. aeruginosa’s aco system induction. Furthermore, acetoin is catabolized by P. aeruginosa , a metabolic process that improves the survival of both pathogens by providing a new carbon source for P. aeruginosa and avoiding the toxic accumulation of acetoin on S. aureus . Due to its beneficial effects on both bacteria, acetoin catabolism could testify to the establishment of trophic cooperation between S. aureus and P. aeruginosa in the CF lung environment, thus promoting their persistence.
- Open Access
Most of Staphylococcus aureus and Pseudomonas aeruginosa co-infecting isolates coexist, a condition that may impact clinical outcomes in Cystic Fibrosis patients
Staphylococcus aureus (SA) is the major colonizer of the lung of cystic fibrosis (CF) patient during childhood and adolescence. As patient aged, the prevalence of SA decreases and Pseudomonas aeruginosa (PA) becomes the major pathogen infecting adult lungs. Nonetheless, SA remains significant and patients harbouring both SA and PA are frequently found in worldwide cohort. Impact of coinfection remains controversial. Furthermore, co-infecting isolates may compete or coexist. The aim of this study was to analyse if co-infection and coexistence of SA and PA could lead to worse clinical outcomes. The clinical and bacteriological data of 212 Lyon CF patients were collected retrospectively, and patients were ranked into three groups, SA only (n=112), PA only (n=48) or SA plus PA (n=52). In addition, SA and PA isolates from co-infecting patients were tested in vitro to define their interaction profile. Sixty five percent (n=34) of SA/PA pairs coexist. Using univariate and multivariate analysis, we confirm that SA patients have a clinical condition less severe than others, and PA induce a poor outcome independently of the presence of SA. FEV1 is lower in patients infected by competition strain pairs than in those infected by coexisting strain pairs compared to SA mono-infection. Coexistence between SA and PA may be an important step in the natural history of lung bacterial colonization within CF patients.
Open AccessMost of Staphylococcus aureus and Pseudomonas aeruginosa co-infecting isolates coexist, a condition that may impact clinical outcomes in Cystic Fibrosis patients
Staphylococcus aureus (SA) is the major colonizer of the lung of cystic fibrosis (CF) patient during childhood and adolescence. As patient aged, the prevalence of SA decreases and Pseudomonas aeruginosa (PA) becomes the major pathogen infecting adult lungs. Nonetheless, SA remains significant and patients harbouring both SA and PA are frequently found in worldwide cohort. Impact of coinfection remains controversial. Furthermore, co-infecting isolates may compete or coexist. The aim of this study was to analyse if co-infection and coexistence of SA and PA could lead to worse clinical outcomes. The clinical and bacteriological data of 212 Lyon CF patients were collected retrospectively, and patients were ranked into three groups, SA only (n=112), PA only (n=48) or SA plus PA (n=52). In addition, SA and PA isolates from co-infecting patients were tested in vitro to define their interaction profile. Sixty five percent (n=34) of SA/PA pairs coexist. Using univariate and multivariate analysis, we confirm that SA patients have a clinical condition less severe than others, and PA induce a poor outcome independently of the presence of SA. FEV1 is lower in patients infected by competition strain pairs than in those infected by coexisting strain pairs compared to SA mono-infection. Coexistence between SA and PA may be an important step in the natural history of lung bacterial colonization within CF patients.